| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 225 | 111 | 0 | 0 | 2.444 | 12.102 | 22.337 | 32.859 | 26.538 | 31.530 |
| Total Income - EUR | 225 | 111 | 0 | 0 | 2.444 | 12.102 | 22.337 | 32.859 | 26.538 | 32.393 |
| Total Expenses - EUR | 38 | 10 | 0 | 0 | 4.685 | 8.910 | 19.707 | 19.055 | 26.168 | 20.584 |
| Gross Profit/Loss - EUR | 187 | 102 | 0 | 0 | -2.240 | 3.192 | 2.630 | 13.804 | 369 | 11.809 |
| Net Profit/Loss - EUR | 180 | 98 | 0 | 0 | -2.314 | 3.021 | 2.052 | 13.089 | 159 | 9.772 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Almar Pediatrica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 40.782 | 29.475 | 20.084 | 9.303 | 1.302 |
| Current Assets | 906 | 992 | 972 | 954 | 296 | 5.195 | 14.004 | 3.854 | 2.318 | 13.679 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 558 | 552 | 543 | 533 | 0 | 190 | 353 | 490 | 309 | 2.635 |
| Cash | 348 | 440 | 429 | 421 | 296 | 5.004 | 13.651 | 3.365 | 2.009 | 11.044 |
| Shareholders Funds | 899 | 988 | 972 | 954 | -1.336 | 1.721 | 2.158 | 15.254 | 9.301 | 9.880 |
| Social Capital | 45 | 45 | 44 | 43 | 84 | 93 | 91 | 91 | 91 | 90 |
| Debts | 7 | 3 | 0 | 0 | 1.632 | 44.256 | 41.320 | 8.685 | 2.319 | 5.101 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Almar Pediatrica Srl